Drug recall · October 21, 2015
Metformin Hydrochloride Extended-Release Tablets recall
Why: Failed Dissolution Specifications: Low Out-of-Specification results for the 8 hour timepoint.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Metformin Hydrochloride Extended-Release Tablets, 1000 mg, 60-count bottle, Rx only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314 USA; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054 USA; NDC 0591-2720-60; UPC 3 05912 72060 3.
- Lots / codes
Lot: 1037736A, Exp 03/18
- Quantity
- 13,284 bottles
- Company
- Actavis Laboratories, FL, Inc., Davie, FL
- Distribution
- Nationwide and Puerto Rico
- Initiated
- September 25, 2015 · Voluntary: Firm initiated
- Classified
- October 13, 2015
- Reported
- October 21, 2015
- Ended
- April 10, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Metformin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.